I am a healthcare professional

Notice


Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.


Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.


By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.


Cookies


We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.


You can find out more about cookies by browsing our Privacy Policy.

 

I am a healthcare professional in Canada

Required field.

For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Infectious Disease ADLM 2024
Roche at

ADLM 2024

July 28 - August 01
Chicago, USA
adlm.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon

Sign up or login to unlock the full suite of MEDICALLY features
Jul 31 / Roche
Result precision on the new Cobas Pro integrated solutions Cobas ISE neo and Cobas c 703 analytical units under routine-like conditions across two sites in Europe
In this study the precision of the new Cobas® Pro integrated solutions Cobas ISE neo and Cobas c 703 analytical units was measured under intended use conditions in a routine simulation setting. The findings from this multicenter study demonstrate that the new ISE neo and c 703 analytical units show consistent results over a prolonged period, with most CVs in this setting below 0.9%. Moreover, successful integration of the new analytical units into the Pro integrated solutions, with seamless interaction of existing and analytical units under stressed conditions, is shown.
Infectious Disease Sexually transmitted disease ADLM-2024

Sign up or login to unlock the full suite of MEDICALLY features
Jul 31 / Roche
CLSI-based result precision on the Cobas ISE neo and Cobas c 703 analytical units across two sites in Europe
In this study the novel Cobas® Pro integrated solutions analytical units, the Cobas ISE neo and the Cobas c 703 analytical units, were assessed at two sites in Europe. Both analytical units demonstrated robust precision, comparable with the existing Pro integrated solutions analytical units, over a prolonged period.
Infectious Disease Sexually transmitted disease ADLM-2024

Sign up or login to unlock the full suite of MEDICALLY features
Jul 30 / Roche
Clinical Performance Evaluation of the Polymerase Chain Reaction (PCR)-Based Cobas CT/NG/MG Test for Use on the Cobas Liat System in a Clinical Laboratory Setting and Point-of-Care (POC) Location
This clinical performance evaluation of the Cobas® Liat CT/NG/MG nucleic acid test, conducted in diverse clinical settings across the United States, aimed to address the challenges posed by sexually transmitted infections (STIs) such as Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Mycoplasma genitalium (MG). The results highlighted the good clinical performance of the Cobas Liat CT/NG/MG test, particularly in providing rapid lab-quality testing at the point of care for both self- and clinician-collected samples. In clinical settings, the test was identified as a tool to provide rapid testing for CT, NG, and MG infections, offering the potential to minimize the need for empiric treatment. This presents an opportunity to improve clinical outcomes for patients and enhance antimicrobial stewardship. An audio accompaniment to this poster was made available to online participants ADLM 2024.
Infectious Disease Sexually transmitted disease ADLM-2024
02:30 PM
Duration 24hrs Chicago, USA
Clinical Performance Evaluation of the Polymerase Chain Reaction (PCR)-Based Cobas CT/NG/MG Test for Use on the Cobas Liat System in a Clinical Laboratory Setting and Point-of-Care (POC) Location
Barbara Van Der Pol
Infectious Disease | Sexually transmitted disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
02:30 PM
Duration 24hrs Chicago, USA
Result precision on the new Cobas Pro integrated solutions Cobas ISE neo and Cobas c 703 analytical units under routine-like conditions across two sites in Europe
Anja Thorenz, Peter Findeisen, Inger Brandt, Frederic Winnock, Jan Furrer
Infectious Disease | Sexually transmitted disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 24hrs Chicago, USA
CLSI-based result precision on the Cobas ISE neo and Cobas c 703 analytical units across two sites in Europe
Anja Thorenz, Peter Findeisen, Inger Brandt, Frederic Winnock, Jan Furrer
Infectious Disease | Sexually transmitted disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.